Why Patent Trolls Threaten Biotech

The backlash following the Blackberry patent dispute would hurt patents in the life sciences

Written byRonald I. Eisenstein
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

In the last few months, much has been written about a patent dispute that threatened to terminate Blackberry service. In the end, a shutdown was averted because Research In Motion (RIM), the company that manufactures Blackberry, paid $612 million to NTP to settle the dispute. The case, however, has triggered a dangerous call for patent reform that could hurt the life sciences industry.

Some of the news accounts of the patent battle sounded almost like a fairy tale. There was poor RIM under assault by "patent trolls" - the definition of which varies, from someone who opportunistically buys some unused patent and then enforces it vigorously against the industry, to anybody enforcing a patent that it does not intend to commercialize. NTP, one of the trolls, was accused of unfairly attacking RIM in a way that would prevent the Blackberry manufacturer from having its day in court. In fact, RIM ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies